SABR-5 Results Are Not Reliable in Assessing Improvement or Maintenance of Quality of Life Without Comparable Evaluation in Control Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SABR-5 Results Are Not Reliable in Assessing Improvement or Maintenance of Quality of Life Without Comparable Evaluation in Control Patients

Published:2024-07 Issue:7 Volume:36 Page:e235-e236
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Macbeth F.^ORCID,Treasure T.^ORCID

Publisher

Elsevier BV

Reference11 articles.

1. Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial;Cruz-Lim;Clin Oncol (R Coll Radiol),2024

2. Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II Trial;Cruz-Lim;Clin Oncol (R Coll Radiol),2024

3. Removal or ablation of asymptomatic lung metastases should be reconsidered;Macbeth;BMJ,2023

4. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial;Palma;Lancet,2019

5. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial;Palma;J Clin Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3